2026 and Vaccines - Pharmacy Technician Pulse

Passport to Protection: Best Practices for Travel Vaccines in the Pharmacy Setting

Drug Topics

JUNE 6, 2025

Garofoli, PharmD, BCACP, CTTS, FAPhA Publication Article Drug Topics Journal Drug Topics May/June 2025 Volume 169 Issue 03 Pharmacy team members can help patients prepare for upcoming travels, ensuring they are up to date with the recommended vaccines for their locations. The first resource is the CDC’s Yellow Book.

Vaccines

Vaccines Immunization Compounding Specialty Pharmacies

FDA Recommends 2025-2026 COVID-19 Vaccines Be Monovalent, Target LP.8.1 Strain

Pharmacy Times

MAY 27, 2025

Following a meeting of the Vaccines and Related Biological Products Advisory Committee, the FDA announced their recommendation of COVID-19 vaccines targeting LP.8.1, a strain of the JN.1 1 variant that has become dominant in the US.

Vaccines

Vaccines FDA

Pharmacists Can Simplify the Vaccine Schedule

Pharmacy Times

JULY 22, 2025

RSV vaccines are recommended for older adults and those with specific health conditions, with options like Arexvy, mResvia, and Abrysvo available. RSV vaccines are recommended for older adults and those with specific health conditions, with options like Arexvy, mResvia, and Abrysvo available.

Vaccines

Vaccines Immunization Compounding Pharmacies FDA

ACIP Votes Against Thimerosal Vaccines for Prevention of Influenza

Drug Topics

JUNE 27, 2025

In a vote of 5 to 1 on Thursday, members of the Advisory Committee on Immunization Practices (ACIP) voted to recommend against influenza vaccine containing the preservative thimerosal. The recommendations include all US adults as well as recommending pregnant women also receive a thimerosal-free vaccine for influenza.

Vaccines

Vaccines Independent Pharmacies Immunization Compounding

New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell Lymphoma

Pharmacy Times

JUNE 27, 2025

Mary Dzhuryan is a class of 2026 PharmD candidate at the USC Alfred E. Mehrnaz Razavi Vakhshoori is a class of 2026 PharmD candidate at the USC Alfred E. The recent application was granted both priority review and orphan drug designation. Mann School of Pharmacy and Pharmaceutical Sciences in Los Angeles.

FDA

FDA Compounding Pharmacies Immunization Chemotherapy

Under the Weather: Unpacking the Impact of the 2024-2025 Influenza Season

Pharmacy Times

JULY 21, 2025

Fournier, BSc Key Takeaways The 2024-2025 influenza season saw unprecedented severity, with high hospitalization and outpatient visit rates due to a vaccine mismatch and dominant H1N1 and H3N2 strains. Targeted public health strategies are needed to improve vaccine access, education, and trust, particularly in underserved communities.

Vaccines

Vaccines Immunization Hospitals Compounding Pharmacies

Carefully Monitor Direct Oral Anticoagulant Medications

Pharmacy Times

JULY 26, 2025

1-4 About the Author Sinem Yasil is a 2026 PharmD candidate at the South College School of Pharmacy in Knoxville, Tennessee. Apixaban, edoxaban, and rivaroxaban inhibit factor Xa, while dabigatran inhibits thrombin, achieving similar anticoagulant effects. 5 A CBC provides information on an individual’s hematologic status.

Compounding Pharmacies

Compounding Pharmacies Vaccines Immunization Hospitals

USP announces new Advanced Technologies Laboratory to accelerate and scale pharmaceutical manufacturing innovations

Pharmacy Times

JUNE 4, 2025

USP plans to continue expanding its advanced technology footprint into an additional 8,000 square foot laboratory in 2026. The Advanced Technologies Lab is the latest of USP’s investments in advanced manufacturing technologies. Learn more about USP’s supply chain solutions.

Compounding Pharmacies

Compounding Pharmacies Compounding Immunization Specialty Pharmacies

Turning Reconciliation into a Revenue Growth Engine

Drug Topics

JUNE 23, 2025

For instance, the MFP is expected to affect approximately 10 drugs in 2026, with the list expanding annually, potentially creating a $22,000 monthly financial impact for average retail pharmacies.

Patient Care

Patient Care Vaccines Specialty Pharmacies Compounding

Real-World Data Shows Similar Clinical Outcomes in Patients Receiving Biosimilars Following Switch From Reference Product

Pharmacy Times

JULY 4, 2025

link] Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Subscribe Now!

Specialty Pharmacies

Specialty Pharmacies Hospitals Compounding Pharmacies Vaccines

Lumateperone Submits Application for Schizophrenia Indication to FDA for Supplemental New Drug

Pharmacy Times

JULY 10, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

FDA

FDA Hospitals Compounding Pharmacies Immunization

FDA Approves Clesrovimab-cfor for Prevention of RSV in Infants

Drug Topics

JUNE 10, 2025

Exclusion criteria included having a bleeding disorder or having received any vaccine or monoclonal antibody for the prevention of RSV. Merck said in the release that it anticipates ordering of clesrovimab-cfor to begin in July, with shipments being delivered before the start of the 2025-2026 RSV season.

FDA

FDA Vaccines Adverse Reactions Specialty Pharmacies

Oveporexton Demonstrates Statistically Significant, Clinically Meaningful Improvements in Patients With NT1

Pharmacy Times

JULY 24, 2025

6 A new drug application (NDA) with the FDA and global regulators are expected to be filed by March 2026, according to the manufacturers. Impressively, over 95% of trial completers entered the ongoing long-term extension study, reflecting both tolerability and sustained interest among participants.

Compounding Pharmacies

Compounding Pharmacies FDA Immunization Compounding

Sanofi to Begin Globally Shipping Beyfortus Ahead of RSV Season

Pharmaceutical Commerce

JUNE 9, 2025

Image Credit: Adobe Stock Images/Artur.com Key Takeaways Sanofi is shipping Beyfortus early to ensure strong supply for the 2025–2026 RSV season and avoid past shortages. and outperformed maternal vaccines in public health programs. Sanofi, AstraZeneca Launch Program to Mitigate Future RSV Vaccine Shortages. June 9, 2025.

Vaccines

Vaccines Immunization Hospitals Pharmaceutical Companies

Locked in a federal stalemate, states take PBM reform into their own hands

PharmaVoice

JUNE 16, 2025

1, 2026, The healthcare giant also said the law would result in Arkansas paying more for prescription drugs. The PBM lobbying group Pharmaceutical Care Management Association also filed a suit last week, claiming Arkansas’ ban is unconstitutional and would impact accessibility due to pharmacies closing their doors.

Independent Pharmacies

Independent Pharmacies Community Pharmacies Vaccines

Trade Policy Shifts: Compliance and Cost Strategies for Pharma

PharmTech

JULY 24, 2025

Removes Thimerosal from Flu Vaccines Patrick Lavery Following an overhaul at ACIP, the HHS secretary took the advice of the committee’s new members, saying he was acting on guidance that dated back to 1999. Subscribe Now! Related Videos Related Content Advertisement July 24th 2025 Opposing Reactions as RFK Jr.

Dosage

Dosage Vaccines Packaging Documentation

Acumen and JCR partner on brain delivery therapy for Alzheimer’s

Pharmaceutical Technology

JULY 16, 2025

How will RFK Jr’s American dream for vaccines play out? Anticipated next steps involve generating preclinical candidate data packages, which will include non-human primate studies expected in early 2026. Following these outcomes, Acumen holds exclusive rights to develop up to two development candidates.

Packaging

Packaging Communication Hospitals Insurance

MHRA approves needle-free adrenaline nasal spray for anaphylaxis

Pharmaceutical Technology

JULY 18, 2025

How will RFK Jr’s American dream for vaccines play out?

Packaging

Packaging Communication Hospitals Pharmaceutical Companies

Op-Ed: Celebrate Direct-to-Career Paths and Primary Care Pharmacy Practice

Pharmacy Times

JUNE 10, 2025

Pharmacy schools are expected to graduate 8,000 student pharmacists in 2026…” [Instagram post]. North American Pharmacist Licensure Examination Passing Rates for 2022-2024 Graduates. National Association of Boards of Pharmacy. January 21, 2025. Accessed June 6, 2025. aacpharmacy. March 12, 2025. Accessed June 6, 2025.

Compounding Pharmacies

Compounding Pharmacies Hospitals Immunization Compounding

FDA to Evaluate Merck’s Doravirine, Islatravir Regimen for HIV-1

Drug Topics

JULY 10, 2025

1 The FDA set a Prescription Drug User Fee Act (PDUFA) date of April 28, 2026. The FDA has accepted for review a New Drug Application (NDA) for doravirine/islatravir for adult patients with HIV-1 infection that is virologically suppressed on antiretroviral therapy, Merck announced in a release.

FDA

FDA Vaccines Specialty Pharmacies Compounding

FDA approves KalVista’s Ekterly for hereditary angioedema

Pharmaceutical Technology

JULY 7, 2025

How will RFK Jr’s American dream for vaccines play out? KalVista will receive an upfront payment of $11m, with an additional $11m contingent upon achieving a regulatory milestone anticipated by early 2026. In April 2025, KalVista Pharmaceuticals granted Kaken Pharmaceutical the commercialisation rights for sebetralstat in Japan.

FDA

FDA Packaging Communication Hospitals

Tariffs & Trade Policy: What to Watch for, Cost Impacts, and Supply Chain Strategies

PharmTech

JULY 24, 2025

Removes Thimerosal from Flu Vaccines Patrick Lavery Following an overhaul at ACIP, the HHS secretary took the advice of the committee’s new members, saying he was acting on guidance that dated back to 1999. Subscribe Now! Related Videos Related Content Advertisement July 24th 2025 Opposing Reactions as RFK Jr.

Dosage

Dosage Vaccines Pharmaceutical Companies Pharmaceutical Companies

Pneumococcal Burden Remains Despite Immunization Expansion

Drug Topics

JUNE 9, 2025

Investigators found that incorporating either the pneumococcal conjugate vaccine (PCV) 20 or PCV 15 and the 23-valent pneumococcal polysaccharide vaccine (PPSV23) had an incremental budget impact of $6.5 2,3 In June 2024, the ACIP announced updates to the vaccine schedule to prevent invasive pneumococcal disease.

Immunization

Immunization Vaccines Independent Pharmacies Specialty Pharmacies

Kling Bio and Sanofi link for antibodies and epitopes discovery

Pharmaceutical Technology

JULY 24, 2025

July 24, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The companies aim to gain insights that could contribute information towards designing more vaccines. We are excited to combine our expertise with Sanofi’s leadership in vaccine development to advance next-generation therapeutics and vaccines.”

Vaccines

Vaccines Packaging Communication Immunization

Looking Beyond mRNA-based COVID-19 Vaccines to Innovative Therapeutics

PharmTech

JUNE 24, 2025

cancer and vaccines), and non-immunogenic applications (e.g., cancer and vaccines), and non-immunogenic applications (e.g., Several types of mRNA-based vaccines have emerged, namely non-replicating linear mRNAs (NRM), self-amplifying mRNAs (saRNAs), and circular mRNAs (circRNAs). Types of messenger RNA (mRNA)-based vaccines.

Vaccines

Vaccines Dosage FDA Immunization

FDA approves Takeda’s Gammagard liquid ERC for primary immunodeficiency

Pharmaceutical Technology

JULY 1, 2025

How will RFK Jr’s American dream for vaccines play out? Takeda anticipates commencing commercialisation efforts for Gammagard liquid ERC in the US by 2026, with plans to follow suit in the European Union (EU) by 2027. GlobalData Strategic Intelligence US Tariffs are shifting - will you react or anticipate?

FDA

FDA Packaging Communication Hospitals

Vertex and NHS England agree reimbursement for Alyftrek

Pharmaceutical Technology

JULY 15, 2025

How will RFK Jr’s American dream for vaccines play out?

Packaging

Packaging Communication Hospitals Vaccines

Aenova Adds Cold Chain Warehouse to Latina, Italy Site

PharmTech

JUNE 27, 2025

Construction on the new warehouse began in early 2025, and the company expects the facility to be operational in the first quarter of 2026. Looking Beyond mRNA-based COVID-19 Vaccines to Innovative Therapeutics Cheryl Barton June 24th 2025 Article mRNA technologies offer great promise in immunotherapy and non-immunogenic applications.

Dosage

Dosage Vaccines Communication

Sanofi to acquire Vicebio’s share capital for $1.15bn upfront

Pharmaceutical Technology

JULY 23, 2025

July 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The acquisition includes vaccine candidates for respiratory syncytial virus and human metapneumovirus. These fully liquid vaccines can be provided in prefilled syringes, improving safety, ease of use and operational efficiency in healthcare settings.

Health and Personal Care Stores

Health and Personal Care Stores Vaccines Packaging Communication

Health Canada extends Evkeeza approval for children with HoFH

Pharmaceutical Technology

JULY 15, 2025

How will RFK Jr’s American dream for vaccines play out?

Packaging

Packaging Communication Hospitals Vaccines

FDA to review MSD’s doravirine/islatravir NDA for HIV-1

Pharmaceutical Technology

JULY 14, 2025

How will RFK Jr’s American dream for vaccines play out? A target action date of 28 April 2026 has been set under the Prescription Drug User Fee Act (PDUFA). Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest EC approves BeOne’s Tevimbra for nasopharyngeal carcinoma Formulate Faster.

FDA

FDA Packaging Hospitals Research Laboratories

GSK eyes FDA label expansion for RSV vaccine Arexvy to include younger patients

Pharmaceutical Technology

JULY 14, 2025

How will RFK Jr’s American dream for vaccines play out? Robert Barrie July 14, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Broader label coverages for Pfizer and Moderna’s vaccines mean they have made in-roads into GSK’s RSV dominant market share. A decision by the FDA is expected in H1 2026.

Labelling

Labelling Vaccines FDA Packaging

Antares Therapeutics gains $177m for cancer medicines development

Pharmaceutical Technology

JUNE 11, 2025

June 11, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The company intends to introduce its inaugural product candidate into clinical trials by 2026. The company is progressing several programmes, intending to introduce its inaugural product candidate into clinical trials by 2026.

Communication

Communication Hospitals Packaging Insurance

UK government targets manufacturing as it eyes £41bn life science sector growth

Pharmaceutical Technology

JULY 16, 2025

How will RFK Jr’s American dream for vaccines play out?

Packaging

Packaging Communication Hospitals Pharmaceutical Companies

JCR Pharma and Alexion partner on JUST-AAV gene therapy platform

Pharmaceutical Technology

JULY 9, 2025

How will RFK Jr’s American dream for vaccines play out? The financial impact of this agreement on JCR’s consolidated results for the fiscal year ending 31 March 2026 has already been included in the current earnings forecast. JUST-AAV is a proprietary platform technology that employs modified AAV vectors.

Packaging

Packaging Communication Hospitals Insurance

GSK’s Blenrep US comeback hindered by eye safety concerns

Pharmaceutical Technology

JULY 16, 2025

How will RFK Jr’s American dream for vaccines play out?

Documentation

Documentation FDA Communication Packaging

Sino Biopharma spends $951m to acquire China-based LaNova Medicines

Pharmaceutical Technology

JULY 15, 2025

How will RFK Jr’s American dream for vaccines play out?

Packaging

Packaging Communication Hospitals Vaccines

PEPFAR funding protection offers “hope” for people living with HIV

Pharmaceutical Technology

JULY 16, 2025

How will RFK Jr’s American dream for vaccines play out?

Packaging

Packaging Communication Hospitals Insurance

WHO endorses Gilead’s Yeztugo for HIV prevention

Pharmaceutical Technology

JULY 14, 2025

How will RFK Jr’s American dream for vaccines play out? The WHO says that the vaccine offers a highly effective, long-acting alternative to daily oral pills and other shorter-acting options. The approval of Yeztugo was hailed as a historical breakthrough by HIV experts and charities. Sign up for our daily news round-up!

Vaccines

Vaccines Packaging Hospitals Communication

Ultragenyx receives complete response letter for UX111 BLA

Pharmaceutical Technology

JULY 14, 2025

How will RFK Jr’s American dream for vaccines play out? While the CRL will delay the potential approval of UX111 to 2026, we are working with urgency to respond and resubmit.” We have been diligently responding to the recent CMC observations and our priority is to resolve them so that we can resubmit the BLA as soon as possible. “We

Communication

Communication Packaging Hospitals FDA

Can rare disease research in the US thrive under the new administration?

Pharmaceutical Technology

JULY 18, 2025

How will RFK Jr’s American dream for vaccines play out? However, the PRV program for rare pediatric diseases is at risk of expiry in September 2026, and is pending renewal.

FDA

FDA Packaging Communication Hospitals

LEO Pharma secures rights to Boehringer’s Spevigo for $105m

Pharmaceutical Technology

JULY 15, 2025

How will RFK Jr’s American dream for vaccines play out? Danish dermatology leader LEO Pharma has bought the rights to Boehringer Ingelheim’s psoriasis drug Spevigo (spesolimab) for €90m ($105m), strengthening its portfolio ahead of a possible public listing in 2026.

Packaging

Packaging Communication Hospitals Vaccines